Approvals/CIMA-AEMPS/ZYNLONTA 10 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

ZYNLONTA 10 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Swedish Orphan Biovitrum Ab (Publ)🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 118807d146d53b6b
Drug Cima Aemps Name: ZYNLONTA 10 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1221695001
Holder Company Name: Swedish Orphan Biovitrum Ab (Publ)
Marketing Company Name: Swedish Orphan Biovitrum S.L.
Holder Company Detail Path: /organization/swedish-orphan-biovitrum-ab-publ
Authorization Date: 2023-05-08
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 10 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Swedish Orphan Biovitrum Ab (Publ)
Company Detail Path: /organization/swedish-orphan-biovitrum-ab-publ

LONCASTUXIMAB TESIRINA

10 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 8, 2023

Approval ID

118807d146d53b6b

Type

Standard